Sectors
AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
AbbVie Inc (ABBV.N) is to buy Pharmacyclics Inc (PCYC.O) for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field.
Premature to talk about third Greek bailout: EU's Juncker
It is too early to discuss a third bailout package for Greece, European Commission President Jean-Claude Juncker said on Wednesday, stressing the focus of talks with Athens was implementing measures already agreed with the euro zone.
China defense budget rise to defy slowing economy
China's defense budget this year will rise about 10 percent compared with 2014, a top government official said on Wednesday, outpacing the slowing economy as the country ramps up investment in high-tech equipment such as submarines and stealth jets.
Fed's Evans wants no rate hikes until early 2016
The Federal Reserve should wait until next year before raising interest rates or risk undermining the very recovery it has helped engineer, a top U.S. central banker said on Wednesday.




